-
ER-Targeting Peptide Self-Assembly in Cancer Cells
2026-08-20
The reference study develops an alkaline-phosphatase-triggered peptide that combines enzyme-instructed self-assembly with p-toluenesulfonamide-mediated endoplasmic reticulum targeting. Its assemblies selectively accumulate in ALP-rich cancer cells, induce ER stress and dysfunction, and promote apoptosis and necroptosis with more than a twofold improvement in IC50 relative to a non-ER-targeting intracellular EISA design.
-
Dinaciclib and Tissue Boundary Mechanics
2026-08-19
Dinaciclib (SCH727965) is a potent multi-CDK inhibitor for linking cell-cycle control with epithelial mechanics. This article develops a mechanobiology-aware assay framework that distinguishes proliferation-dependent boundary remodeling from apoptosis and direct cytoskeletal effects.
-
How Ions Improve CPP-Mediated Nucleic Acid Delivery
2026-08-19
The 2024 study shows that biocompatible ions are active formulation variables in cell-penetrating peptide–nucleic acid nanoparticles, altering particle properties and improving productive delivery. Its strongest mechanistic implication is that ion supplementation can enhance endosomal escape without fundamentally redirecting nanoparticle internalization.
-
nor-NOHA and the Next Wave of Arginase Research
2026-08-18
A translational perspective on nor-NOHA acetate as a reversible arginase probe, linking arginine metabolism, HepG2 phenotypes, endothelial biology, and emerging immune-metabolic questions in AML.
-
Ion Homeostasis as a Translational Biomarker Lever
2026-08-18
5-(N,N-dimethyl)-Amiloride hydrochloride offers a mechanistically focused way to interrogate Na+/H+ exchanger biology across cardiac and endothelial injury models. This thought-leadership perspective connects intracellular pH regulation and sodium transport with moesin-centered biomarker research in sepsis, while outlining practical validation strategies and translational limitations.
-
2-Hydroxypropyl-β-cyclodextrin Protocol Guide
2026-08-17
2-Hydroxypropyl-β-cyclodextrin is a water-compatible cyclic oligosaccharide solubilizer for poorly water-soluble hydrophobic compounds, particularly molecules with aromatic or phenyl groups. It is appropriate for drug formulation excipient and biochemical solubility workflows, but inclusion, stability, bioavailability, and downstream biological effects require assay-specific validation.
-
WST-8 Glucose Uptake Assay Kit: Lab Guide
2026-08-17
This scenario-based guide explains how the WST-8 Glucose Uptake Assay Kit, SKU K2303, supports quantitative, non-radioactive measurement of cellular glucose uptake. It covers assay principles, compatibility with viability and cytotoxicity workflows, protocol controls, data interpretation, and practical vendor-selection criteria.
-
From ROS Signal to Translational Insight
2026-08-16
A mechanistic and strategic guide to using DCFH-DA-based live-cell ROS measurements to connect oxidative stress biology with translational research, illustrated by sulforaphane protection in PM2.5-induced COPD models.
-
E-64 for Reliable Cysteine Protease Assays
2026-08-15
This scenario-driven guide explains how E-64 (SKU A2576) can improve mechanistic interpretation of cell viability, proliferation, and cytotoxicity assays through quantitative cysteine protease inhibition. It covers assay design, solvent and stock handling, data interpretation, cross-domain limitations, and practical criteria for selecting a reliable supplier.
-
Atorvastatin Workflows for Vascular and Ferroptosis Research
2026-08-14
Atorvastatin is a versatile HMG-CoA reductase inhibitor for connecting cholesterol-pathway perturbation with vascular phenotypes, endoplasmic reticulum stress, and ferroptosis-related cancer biology. This practical guide provides formulation guidance, assay workflows, quantitative starting points, and troubleshooting strategies for cardiovascular and hepatocellular carcinoma models.
-
Multianimal MRI for Pancreatic Tumor Monitoring
2026-08-14
Kempinska and colleagues present a four-chamber MRI workflow that images up to four pancreatic cancer-bearing mice in one acquisition, improving the efficiency of tumor detection and longitudinal measurement in KPC models. The protocol also provides a practical framework for evaluating gemcitabine treatment response while clarifying how anatomical imaging should be combined with mechanistic and pathological endpoints.
-
Hyperthermia–Cisplatin Activates Caspase-8
2026-08-13
The 2024 study identifies a mechanistic link between hyperthermia, cisplatin, and caspase-8 stabilization through CUL3-regulated K63-linked polyubiquitination and p62 interaction. This caspase-8-centered pathway enhanced both caspase-3-associated apoptosis and gasdermin-linked pyroptosis, providing a rationale for measuring caspase-8 activity alongside complementary cell-death assays.
-
Moxidectin–Polyenes Synergy in Oral Candidiasis
2026-08-13
A 2024 study showed that Moxidectin enhances amphotericin B and nystatin activity against Candida albicans by increasing fungal ergosterol biosynthesis and polyene binding. Transcriptomic, mutant, biochemical, and mouse-model data support a target-complementary combination strategy, while clinical translation remains unestablished.
-
Separating Growth Arrest from Cancer Cell Death
2026-08-12
Hannah Schwartz’s dissertation argues that in vitro anti-cancer drug testing should distinguish relative viability from fractional viability because these measures combine or resolve different biological outcomes. Its central implication is practical: drug-response studies need time-aware, parallel measurements of proliferation and cell killing to avoid treating growth inhibition as a direct proxy for cytotoxicity.
-
Resazurin Cell Viability Assay for Wnt Studies
2026-08-12
Learn how the Resazurin Cell Viability Assay Kit can strengthen Wnt and skeletal disease experiments by separating metabolic viability signals from differentiation and pathway effects. This guide translates findings from a sclerosteosis study into practical assay design, controls, and interpretation strategies.